3,4-dihydroxyphenylacetic acid has been researched along with verapamil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damsma, G; de Vries, JB; Hofsteede, HM; Westerink, BH | 1 |
| Nayler, WG; Sturrock, WJ | 1 |
| Reyes, A; Sitges, M | 1 |
| Antkiewicz-Michaluk, L; Romańska, I; Vetulani, J | 1 |
| Gilani, AH; Rashid, F; Saeed, SA; Shah, BH | 1 |
| Büyükuysal, RL | 1 |
| Guarneros, A; Sitges, M | 1 |
7 other study(ies) available for 3,4-dihydroxyphenylacetic acid and verapamil
| Article | Year |
|---|---|
The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Amino Acids; Animals; Brain; Calcium; Calcium Channel Blockers; Dialysis; Dopamine; Haloperidol; Magnesium; Male; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Verapamil | 1988 |
An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Coronary Disease; Diltiazem; Dopamine; Epinephrine; Heart; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains; Species Specificity; Verapamil | 1984 |
Effects of verapamil on the release of different neurotransmitters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Biogenic Monoamines; Dopamine; Hippocampus; In Vitro Techniques; Male; Neostriatum; Potassium; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Presynaptic; Receptors, Serotonin; Spiperone; Synaptosomes; Verapamil | 1995 |
Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Calcium Channel Blockers; Cerebral Cortex; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Nifedipine; Nucleus Accumbens; Rats; Rats, Wistar; Verapamil | 1996 |
Dopamine potentiation of calcium ionophore, A-23187-induced platelet aggregation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Androstadienes; Aspirin; Benzophenanthridines; Calcimycin; Calcium; Chlorpromazine; Diltiazem; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; GTP-Binding Proteins; Haloperidol; Homovanillic Acid; Humans; Indomethacin; Ion Transport; Ionophores; Phenanthridines; Phentolamine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Aggregation; Propranolol; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Dopamine; Serotonin; Signal Transduction; Verapamil; Wortmannin | 1997 |
Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium Channel Blockers; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Guanylate Cyclase; Hydroxylamine; In Vitro Techniques; Kynurenic Acid; Male; Methylene Blue; Nitric Oxide; Nitroprusside; Nomifensine; omega-Conotoxin GVIA; Peptides; Rats; Rats, Sprague-Dawley; Sodium Channels; Tetrodotoxin; Vasodilator Agents; Verapamil | 1997 |
Chronic verapamil modifies striatal and frontal cortex dopamine levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Calcium Channel Blockers; Dopamine; Dopamine Antagonists; Frontal Lobe; Haloperidol; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neostriatum; Rats; Rats, Wistar; Serotonin; Verapamil | 1998 |